30 phenotypes from 4 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Sgcgtm1Mcn/Sgcgtm1Mcn involves: 129X1/SvJ * C57BL/6	abnormal diaphragm morphology	J:49871
	abnormal gait	J:49871
	abnormal heart ventricle morphology	J:49871
	normal behavior/neurological phenotype	J:57664
	coronary artery spasm	J:88456
	decreased body weight	J:49871, J:57664
	decreased heart weight	J:49871
	decreased locomotor activity	J:49871
	dystrophic muscle	J:49871
	increased circulating creatine kinase level	J:49871, J:57664
	normal muscle phenotype	J:57664
	premature death	J:49871
	thick diaphragm muscle	J:49871
	thick ventricular wall	J:49871
Sgcgtm1Oza/Sgcgtm1Oza involves: 129S4/SvJae * C57BL/6	abnormal diaphragm morphology	J:102780
	abnormal muscle regeneration	J:102780
	abnormal tibialis anterior morphology	J:102780
	cardiac fibrosis	J:102780
	dystrophic muscle	J:102780
	increased circulating creatine kinase level	J:102780
	increased skeletal muscle fiber size	J:102780
	increased skeletal muscle mass	J:102780
	muscle degeneration	J:102780
	myocardium necrosis	J:102780
	premature death	J:102780
	progressive muscle weakness	J:102780
	skeletal muscle hypertrophy	J:102780
	skeletal muscle interstitial fibrosis	J:102780
	skeletal muscle necrosis	J:102780
Tg(Ckm-Sgcg)4Mcn/0 involves: C57BL/6 * DBA/2	abnormal gait	J:128649
	abnormal skeletal muscle morphology	J:128649
	centrally nucleated skeletal muscle fibers	J:128649
	decreased body size	J:128649
	decreased locomotor activity	J:128649
	decreased skeletal muscle mass	J:128649
	dystrophic muscle	J:128649
	increased variability of skeletal muscle fiber size	J:128649
	premature death	J:128649
Tg(Ckm-Sgcg)5Mcm/0 involves: C57BL/6 * DBA/2	abnormal gait	J:128649
	decreased body size	J:128649